Image For Activity Cover
Expert Perspective: Outcomes in Fetuses and Neonates with Severe LQTS
Description
HRS member Jeremy P. Moore, MD, MS, FHRS, CCDS, CEPS-P, presents new data showing that fetuses and/or newborns with LQT3, but not those with LQT1 or LQT2, presenting with severe arrhythias are at high risk of frequent and lethal cardiac events. Genotyping is, therefore, useful for risk stratification among affected fetuses and newborns. 
Summary
Availability: On-Demand
Cost: FREE
Credit Offered:
No Credit Offered
Recommended
  Heart Rhythm Society
1325 G Street NW, Suite 400
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy | Linking Policy | Patient Education Disclaimer | State Nonprofit Disclosures | FAQ
 
Android App Download IOS App Download Powered By